AlphaFold predicted structure
RBBP5 · Q15291

Mean pLDDT
77.8/ 100
Confident
538 residues
Confidence breakdown
- Very high(≥ 90)55%
- Confident(70–90)17%
- Low(50–70)8%
- Very low(< 50)19%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
RB binding protein 5, histone lysine methyltransferase complex subunit
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedneurodevelopmental disorder
neurodegenerative disease
Intellectual disability
placental abruption
Abnormality of the skeletal system
digestive system neoplasm
coronary artery disorder
aortic stenosis
type 2 diabetes mellitus
melanoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Retinoblastoma-binding protein 5
In embryonic stem (ES) cells, plays a crucial role in the differentiation potential, particularly along the neural lineage, regulating gene induction and H3 'Lys-4' methylation at key developmental loci, including that mediated by retinoic acid (By similarity). Does not affect ES cell self-renewal (By similarity). Component or associated component of some histone methyltransferase complexes which regulates transcription through recruitment of those complexes to gene promoters (PubMed:19131338). As part of the MLL1/MLL complex, involved in mono-, di- and trimethylation at 'Lys-4' of histone H3 (PubMed:19556245). Histone H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation (PubMed:19556245). In association with ASH2L and WDR5, stimulates the histone methyltransferase activities of KMT2A, KMT2B, KMT2C, KMT2D, SETD1A and SETD1B (PubMed:21220120, PubMed:22266653)
RBBP5 · Q15291

Mean pLDDT
77.8/ 100
Confident
538 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0